aXichem
1.155 SEK -12.83%Be the first to follow this company
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.
Revenue
1.81M
EBIT %
-956.91 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
AXIC A
Daily low / high price
0.9 / 1.32
SEK
Market cap
46.55M SEK
Turnover
170.55K SEK
Volume
148K
Financial calendar
Interim report
23.05.2024
General meeting
19.06.2024
Interim report
27.08.2024
Interim report
28.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
LMK Forward | 12.2 % | 11.1 % |
Manakin Ltd | 9.1 % | 9.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months
aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools